Why is Vivanza Biosci. falling/rising?

As of 18-Nov, Vivanza Biosciences Ltd is currently priced at 2.36, reflecting a decline of 0.12 or 4.84%. The stock has been underperforming, having lost 9.58% over the last two days and underperformed its sector by 4.21% today. Despite this recent downturn, the stock has shown a positive trend over the past week and month, with returns of 19.19% and 18.59%, respectively. However, it has experienced significant declines year-to-date and over the past year, with losses of 32.18% and 42.16%. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 36.86% compared to the five-day average, indicating reduced trading interest.
Broader market context shows that while Vivanza's short-term performance has been strong relative to its recent history, it still lags behind the benchmark Sensex, which has gained 0.96% over the past week and 0.86% over the past month. The stark contrast in performance is highlighted by the stock's year-to-date decline of 32.18% compared to the Sensex's gain of 8.36%. This underperformance in the broader market, coupled with the recent drop in trading volume and consecutive price falls, suggests that investor sentiment may be shifting negatively, contributing to the stock's current decline.